These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21226239)

  • 21. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvants and delivery technologies.
    Killeen KP
    Hum Vaccin; 2009 Oct; 5(10):667-70. PubMed ID: 19556878
    [No Abstract]   [Full Text] [Related]  

  • 23. Cutaneous vaccination with coated microneedles prevents development of airway allergy.
    Shakya AK; Lee CH; Gill HS
    J Control Release; 2017 Nov; 265():75-82. PubMed ID: 28821461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies vaccination in dogs using a dissolving microneedle patch.
    Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
    J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in nanoparticle-based vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
    [No Abstract]   [Full Text] [Related]  

  • 27. Transdermal immunization: biological framework and translational perspectives.
    Mishra DK; Dhote V; Mishra PK
    Expert Opin Drug Deliv; 2013 Feb; 10(2):183-200. PubMed ID: 23256860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Cutaneous Vaccine Adjuvant that STINGs a Little Less.
    Caucheteux SM; Piguet V
    J Invest Dermatol; 2016 Nov; 136(11):2127-2128. PubMed ID: 27772546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-in-oil nanodispersions for transdermal drug delivery systems.
    Kitaoka M; Wakabayashi R; Kamiya N; Goto M
    Biotechnol J; 2016 Nov; 11(11):1375-1385. PubMed ID: 27529824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
    Exley C
    Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel vaccine approaches.
    Woodland DL
    Viral Immunol; 2013 Feb; 26(1):1-2. PubMed ID: 23409928
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination onto bare skin.
    Tang DC; Shi Z; Curiel DT
    Nature; 1997 Aug; 388(6644):729-30. PubMed ID: 9285583
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence versus expert opinion in vaccination practice.
    Cook IF
    Hum Vaccin; 2010 May; 6(5):374-6. PubMed ID: 20484974
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbiota, a forgotten relic of vaccination.
    Lex JR; Azizi A
    Expert Rev Vaccines; 2017 Dec; 16(12):1171-1173. PubMed ID: 29050523
    [No Abstract]   [Full Text] [Related]  

  • 38. [Are there differences in immunogenicity and safety of vaccines according to the injection method?].
    Ajana F; Sana C; Caulin E
    Med Mal Infect; 2008 Dec; 38(12):648-57. PubMed ID: 18986787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can needle-free administration of vaccines become the norm in global immunization?
    Levine MM
    Nat Med; 2003 Jan; 9(1):99-103. PubMed ID: 12514720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.